Greenway Greenhouse Cannabis Corporation
Greenway Greenhouse Cannabis Corporation engages in the cultivation, processing, sale, bulk package, and wholesale of dry bud cannabis. The company was incorporated in 2018 and is headquartered in Kingsville, Canada. Greenway Greenhouse Cannabis Corporation is a subsidiary of Sunrite Greenhouses Ltd.
Greenway Greenhouse Cannabis Corporation (GWAYF) - Net Assets
Latest net assets as of September 2025: $9.90 Million USD
Based on the latest financial reports, Greenway Greenhouse Cannabis Corporation (GWAYF) has net assets worth $9.90 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($32.38 Million) and total liabilities ($22.48 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $9.90 Million |
| % of Total Assets | 30.57% |
| Annual Growth Rate | -0.52% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 34.8 |
Greenway Greenhouse Cannabis Corporation - Net Assets Trend (2021–2025)
This chart illustrates how Greenway Greenhouse Cannabis Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Greenway Greenhouse Cannabis Corporation (2021–2025)
The table below shows the annual net assets of Greenway Greenhouse Cannabis Corporation from 2021 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | $10.05 Million | -15.64% |
| 2024-03-31 | $11.92 Million | -20.29% |
| 2023-03-31 | $14.95 Million | -11.35% |
| 2022-03-31 | $16.86 Million | +64.27% |
| 2021-03-31 | $10.26 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Greenway Greenhouse Cannabis Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1088424700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $29.86 Million | 297.09% |
| Total Equity | $10.05 Million | 100.00% |
Greenway Greenhouse Cannabis Corporation Competitors by Market Cap
The table below lists competitors of Greenway Greenhouse Cannabis Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Archidply Industries Limited
NSE:ARCHIDPLY
|
$4.80 Million |
|
Mr. Onion
TWO:2740
|
$4.80 Million |
|
Truscreen Group Ltd
AU:TRU
|
$4.80 Million |
|
MODELON AB AK B
F:3VM1
|
$4.80 Million |
|
Citigold Corporation Limited
PINK:CTOHF
|
$4.80 Million |
|
Hindcon Chemicals Limited
NSE:HINDCON
|
$4.80 Million |
|
Solartron Public Company Limited
BK:SOLAR
|
$4.79 Million |
|
Thor Energy Plc
AU:THR
|
$4.79 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Greenway Greenhouse Cannabis Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 11,915,049 to 10,051,338, a change of -1,863,711 (-15.6%).
- Net loss of 2,057,449 reduced equity.
- Other factors increased equity by 193,738.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-2.06 Million | -20.47% |
| Other Changes | $193.74K | +1.93% |
| Total Change | $- | -15.64% |
Book Value vs Market Value Analysis
This analysis compares Greenway Greenhouse Cannabis Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.93x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 1.74x to 1.93x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-03-31 | $0.08 | $0.15 | x |
| 2022-03-31 | $0.13 | $0.15 | x |
| 2023-03-31 | $0.11 | $0.15 | x |
| 2024-03-31 | $0.09 | $0.15 | x |
| 2025-03-31 | $0.08 | $0.15 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Greenway Greenhouse Cannabis Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -20.47%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -22.99%
- • Asset Turnover: 0.28x
- • Equity Multiplier: 3.21x
- Recent ROE (-20.47%) is above the historical average (-21.38%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -12.00% | -106.50% | 0.05x | 2.45x | $-2.26 Million |
| 2022 | -17.34% | -147.30% | 0.06x | 2.11x | $-4.61 Million |
| 2023 | -17.43% | -46.35% | 0.16x | 2.36x | $-4.10 Million |
| 2024 | -39.64% | -90.30% | 0.16x | 2.78x | $-5.91 Million |
| 2025 | -20.47% | -22.99% | 0.28x | 3.21x | $-3.06 Million |
Industry Comparison
This section compares Greenway Greenhouse Cannabis Corporation's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Greenway Greenhouse Cannabis Corporation (GWAYF) | $9.90 Million | -12.00% | 2.27x | $4.80 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |